台灣外泌體

LANGUAGE

SCROLL DOWN

2026/07/03 Editorial Column

Private investment and increased government support! The Industrial Development Agency's "Venture Capital Acceleration Innovation and Entrepreneurship Program" has upgraded its second round of applications for the first batch of 10 approved projects, whic
View More
2026/06/22 Editorial Column

[Video] Taiwan Exosome Company Expands Large Animal Preclinical Research Through Strategic Partnership with Waseda University and BioPhenoMA (CNEWS)
View More
2026/06/22 Editorial Column

TEC hosts forum to discuss preclinical research in large animals(（China Times News）
View More
2026/01/21 Editorial Column

Taiwan Exosome Company (TEC) Partners with ATRI to Obtain "SPF Pig Platelet Exosome" Licensing, Targeting Billion-Dollar Global Regenerative Medicine Opportunities
View More
2026/01/16 Editorial Column

Southern Taiwan University of Science and Technology Presents Industry–Academia R&D Achievements in Exosome Technology; Techniques Transferred to Japanese Team for Experimental Validation
View More
2025/12/26 Editorial Column

Taiwan Exosome Company Opens a New Chapter in Regenerative Medicine! Storming the Japanese Bridgehead to Lead the Global Pharmaceutical Market
View More
2025/12/24 Editorial Column

Taiwan Exosome Industry Joins Forces with National Yang Ming Chiao Tung University! Focusing on Urological Diseases
View More
2025/10/02 Editorial Column

Exosome technology targets neurological health — Taiwanese startup builds an integrated academia-industry-clinical platform.
View More
2025/09/19 Editorial Column

Miniature Couriers Between Cells! Taiwan Biotech Startup Targets Urological Applications to Pioneer Regenerative Medicine
View More
2025/09/18 Editorial Column

Taiwan Exosome Company has established the first domestic clinical-grade universal (non-matching and non-genetically modified) NK cell platform, possessing the key capability to enter clinical trials.
View More
2025/09/18 Editorial Column

Exosome Technology on the Rise — Taiwan Exosome’s Strategic Blueprint for Global Market Expansion
View More
2024/01/30 Editorial Column

To enhance the overall operational efficiency of the company, the Board of Directors of Medigen Biotech Corp has resolved to form a strategic alliance with Taiwan Exosome Company.
View More

About us

Company Introduction

Though small,accompllishes big:
New Breakthrough in Regenerative Medicine

Doctors have benevolent hearts and always be devoted to contributing more to people's health. With a strong research team leading the way and staying ahead of the curve
, they pioneer innovations and make significant contributions to emerging industries. They strive to reach the pinnacle of the medical and biotech fields together!